AzTrials
AzTrials

Cleansing Quality of the ColonCALPER2NCT05553977

Artificial Intelligence and Bowel Cleansing Quality

An observational study of Cleansing Quality of the Colon, run by Hospital Universitario de Canarias at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main purpose of the study is to design and validate a convolutional neural network (CNN) with the ability to discriminate between pictures of effluents with different qualities of bowel cleansing and in a second time to prospectively assess in a cohort of patients the agreement between the result of the last… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cleansing Quality of the Colon
What is being tested?
Bowel preparation for colonoscopy and Colonoscopy
Type of treatment
Surgery or procedure
How many people
667 participants
Where
1 siteSpain
Study dates
1 Oct 2022to 30 May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The researchers will offer to participate in the study to patients scheduled for a colonoscopy who meet all the inclusion criteria and none of the exclusion criteria. The researchers will explain the purpose of the study and will ask to sign the informed consent. They will give verbal and written information.

Who may be able to join

  • Age >18, to sign the informed consent,
  • Patients with indication of outpatient colonoscopy
  • Patients ingesting the bowel preparation

Who cannot join

  • Incomplete colonoscopy (except for poor bowel preparation)
  • Contraindication for colonoscopy
  • Allergies.
  • Refusal to participate in the study or impairment to sign the informed consent.
  • Colectomy (more than 1 segment)
  • Dementia with difficulty in the intake of the preparation

Trial locations and contacts

1 site in 1 country.

Antonio Z Gimeno García, MD, PhD contact

+34922678554

antozeben@gmail.com

Spain1 site, 1 recruiting
  • Department of Gastroenterology

    San Cristóbal de La Laguna, S/C de Tenerife, 38320

    Antonio Z Gimeno Garcia, MD, hD, 34922678039, antozeben@gmail.com

    David Nicolas Perez, MD, PhD

    Recruiting

Other trials in Spain

About this study

Official title: Design and Validation of an Artificial Intelligence System to Detect the Quality of Colon Cleansing Before Colonoscopy

The main purpose of the study is to design and validate a convolutional neural network (CNN) with the ability to discriminate between pictures of effluents with different qualities of bowel cleansing and in a second time to prospectively assess in a cohort of patients the agreement between the result of the last rectal effluent quality assessed by the CNN and the cleansing quality assessed during the colonoscopy assessed by a validated scale (Boston Bowel Preparation Scale, BBPS). Patients will be prepared with polyethylene glycol (PEG), PEG plus ascorbic acid (PEG-Asc) or sodium picosulfate-oxide magnesium solution (PS).

Read the detailed description

The patient perception of the last bowel movement before the colonoscopy has been shown a powerful predictor of bowel cleansing rated during colonoscopy. A large study involving 1011 patients distributed in a derivation cohort (633 patients) and a validation cohort (378 patients) using a set of 4 pictures resembling bowel cleansing qualities showed a moderate agreement with the BBPS. In addition, a good agreement was found when the staff perception and patient perception of the last bowel movement were compared. These findings offer an excellent opportunity to test rescue cleansing interventions the same day of the examination, before colonoscopy.

Over the last two years, artificial intelligence applications have wrought a substantial breakthrough in several disciplines, including endoscopy. Machine learning and its more advanced form deep learning, refers to the development of algorithms (convolutional neural networks) with the ability to learn and perform certain tasks. In the endoscopy setting, computer vision applications have been stated as research priority field. Based on all this experience, the aim of this study was to design and to validate a convolutional neural network capable of automatically predicting the quality of the patient cleansing at home after the intake of the bowel cleansing solution and before attending the colonoscopy. The other aim was to prospectively assess in a cohort of patients the agreement between the result of the last rectal effluent quality assessed by the convolutional neural network and the cleansing quality assessed during the colonoscopy assessed by a validated scale (Boston Bowel Preparation Scale, BBPS) This study is nested in an observational prospective study conducted at the Open Access Endoscopy Unit of the Hospital Universitario de Canarias between February 2021 and May 2021 (NCT04702646). A total of 633 consecutive outpatients with a scheduled colonoscopy participated in this study (a total of 266 patients (42%) sent at least one picture). After this study, patients in whom an outpatient colonoscopy was requested, were asked to provide pictures of their effluents during bowel preparation intake. A subgroup of these images will be classified by the personal of our unit in adequate and inadequate and will be used to train the convolutional neural network. Another set of images will be used to validate the convolutional neural network. Additionally, the investigators will validate in-vivo the convolutional neural network comparing its classification of the effluent quality with a validated colon cleansing scale during the colonoscopy.

Being tested
Bowel preparation for colonoscopy, Colonoscopy
Keywords
Bowel cleansing, Colonoscopy, Convolutional Neural Network

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bowel preparation for colonoscopyDrug

    one day liquid diet will be administered to every patient included in the study and: split-dose bowel preparation with 4 Liters of Polyethylene glycol solution, 2 Liters of PEG-Ascorbic acid or 2 Liters Picosulfate.

  • ColonoscopyProcedure or surgery

    Colonoscopy will be performed to every patient included in the study

Study groups in NCT05553977
Study groupRoleWhat they receive
Consecutive patients for outpatient colonoscopyThe researchers will offer to participate in the study to patients scheduled for a colonoscopy who meet all the inclusion criteria and none of the exclusion criteria
Receives: Drug: Bowel preparation for colonoscopy; Procedure: Colonoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effluent characteristics

    Effluent characteristics. Set of 4 pictures categorized in adequate preparation (clear liquid, clear liquid with lumps) and inadequate preparation (dark liquid, or dark liquid with solid particles). The concolutional Neural Network will be trained with effluent images and validated.

    Measured: 1 year

  2. Quality of bowel cleansing assessed by the Boston Bowel Preparation Scale

    Quality of bowel cleansing assessed by the Boston Bowel Preparation Scale. This scale goes from 0 (no preparation) to 3 points (excellent preparation) in the three segments of the colon (proximal, transverse and distal). The maximum score is 9 points

    Measured: 1 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2022
  2. Study start1 Oct 2022
  3. Primary completion20 Apr 2023 (estimated)
  4. Study completion30 May 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
667 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05553977
Sponsor's protocol ID
CNN bowel cleansing
Acronym
CALPER2
Status last verified
Jan 2023
First submitted
19 Sep 2022
Last updated
18 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Mori Y, Misawa M, Kudo SE. Challenges in artificial intelligence for polyp detection. Dig Endosc. 2022 May;34(4):870-871. doi: 10.1111/den.14279. Epub 2022 Mar 22. No abstract available.

    PubMed 35318734
  • Berzin TM, Parasa S, Wallace MB, Gross SA, Repici A, Sharma P. Position statement on priorities for artificial intelligence in GI endoscopy: a report by the ASGE Task Force. Gastrointest Endosc. 2020 Oct;92(4):951-959. doi: 10.1016/j.gie.2020.06.035. Epub 2020 Jun 19.

    PubMed 32565188
  • Fatima H, Johnson CS, Rex DK. Patients' description of rectal effluent and quality of bowel preparation at colonoscopy. Gastrointest Endosc. 2010 Jun;71(7):1244-1252.e2. doi: 10.1016/j.gie.2009.11.053. Epub 2010 Apr 1.

    PubMed 20362286
  • Alzubaidi L, Zhang J, Humaidi AJ, Al-Dujaili A, Duan Y, Al-Shamma O, Santamaria J, Fadhel MA, Al-Amidie M, Farhan L. Review of deep learning: concepts, CNN architectures, challenges, applications, future directions. J Big Data. 2021;8(1):53. doi: 10.1186/s40537-021-00444-8. Epub 2021 Mar 31.

    PubMed 33816053
  • Harewood GC, Wright CA, Baron TH. Assessment of patients' perceptions of bowel preparation quality at colonoscopy. Am J Gastroenterol. 2004 May;99(5):839-43. doi: 10.1111/j.1572-0241.2004.04176.x.

    PubMed 15128347

Questions about this trial

What is this clinical trial studying?

An observational study of Cleansing Quality of the Colon, run by Hospital Universitario de Canarias at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Antonio Z Gimeno García, MD, PhD (+34922678554, antozeben@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effluent characteristics (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05553977, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2023; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in